Since elevated IGF-1 and IGF-1R levels have been associated with many types of cancer and metastases, they cannot be used as prostate cancer markers, at least individually, due to their lack of specificity [59, 60, 63–65]. This evidence concerns the gene IGF1R and prostate cancer.